Deferred Tax Assets, Valuation Allowance in USD of GUIDED THERAPEUTICS INC from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GUIDED THERAPEUTICS INC quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • GUIDED THERAPEUTICS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $17,565,000, a 2.2% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,565,000 -$393,000 -2.2% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $17,958,000 +$894,000 +5.2% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $17,064,000 -$1,122,000 -6.2% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $18,186,000 -$1,222,000 -6.3% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $19,408,000 -$1,623,000 -7.7% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $21,031,000 -$434,000 -2% 31 Dec 2019 10-K 07 Apr 2021 2020 FY
Q4 2018 $21,465,000 -$1,999,000 -8.5% 31 Dec 2018 10-K 20 Apr 2020 2019 FY
Q4 2017 $23,464,000 -$5,986,000 -20% 31 Dec 2017 10-K 08 May 2019 2018 FY
Q4 2016 $29,450,000 +$623,000 +2.2% 31 Dec 2016 10-K/A 20 Apr 2018 2017 FY
Q4 2015 $28,827,000 +$55,287,000 31 Dec 2015 10-K 22 Mar 2017 2016 FY
Q4 2014 $26,460,000 -$3,435,000 -15% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $23,025,000 +$726,000 +3.1% 31 Dec 2013 10-K 25 Mar 2015 2014 FY
Q4 2012 $23,751,000 -$239,000 -1% 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q4 2011 $23,512,000 31 Dec 2011 10-K 27 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.